The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Each to their own. I think this will recover more than 100 percent very soon
Yes thanks for getting back I have taken the director buys into consideration and yes agree with you 30% to 50% recovery is possible
He filtered me because I always ask the negatives and the positives of a share. He just wants me to post the positives all the time and when the **** hits the fan in other shares I’ve been in the negatives where the questions that should have been answered at the time also
Do you still hold in metro or sound energy energy or even tullow oil?
for at "least" 30-50% recovery from here in the VERY short term ;)
"@Carrefour: I think this share is currently price right at the moment (2.5p)"
Well, I dont think the board of directors and the US investors agree with you mate:
3 Oct : Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 250,000 ordinary shares at a price of 5.5 pence per Share. Following the purchase, Mr Stamp's holding in the Company is 450,000 Shares, representing 0.11 per cent. of the Company's issued share capital.
4 Oct : Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 100,000 ordinary shares at a price of 5.89 pence per Share. Following the purchase, Mr Stamp's holding in the Company is 550,000 Shares, representing 0.13 per cent. of the Company's issued share capital.
7 Oct : Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 450,000 ordinary shares at a price of 6.75 pence per Share. Following the purchase, Mr Stamp's holding in the Company is 1,000,000 Shares, representing 0.24 per cent. of the Company's issued share capital.
2 Oct : Midatech announced that an award has been made under the 2014 Midatech Pharma plc Enterprise Management Incentive Scheme to Stephen Stamp, Chief Financial Officer and a Director of the Company. The award consists of 1,000,000 share options over the Company's ordinary shares having a nominal value of 0.005 pence each (the "Options") with an exercise price of 5.25 pence per share.
28 Oct : Midatech announced the closing of its previously announced registered direct offering of 3,000,000 of its American Depositary Shares ("ADSs") (each ADS representing 20 of the Company's ordinary shares (the "New Ordinary Shares")) at a purchase price of US$1.00 per ADS (equivalent to 3.9 pence per share.
The Company issued to the Investor unregistered warrants to purchase up to 3,000,000 ADSs ("Warrant ADSs"). The warrants have an exercise price of US$1.25 per ADS (equivalent to 4.8 pence per New Ordinary Share) .
***Institutional Investors wont buy shares in a company to make loss or to break even. BOD are not obliged to buy shares in their companies unless they wont to.
RSI for MTPH & MTP (Nasdaq listing) currently in the heavily oversold area.
I am a value trader not a long tern investor & I am not interested in holding a position in any company for long term. I very much like what I see here so far and it gives me comfort to know that the company already passed EU and the Spanish government due diligence to access millions of Euros so no ponzi scheme here.
Midatech is oversold on TA charts & CFO felt comfortable to pay 110%, 120% & 135.6% the current sp two months ago to buy nice chunks of shares, his warrants @ 11% the current sp & US ii paid 92% the current sp.
I am happy to buy at this level for 30-50% recovery from here :)
The weekend especially looking at the longer term holders posts over the last year I think this share is currently price right at the moment and that’s not a deramp. The dilution that has happened over the years has knocked the stuffing out of this share. I think it could go up to 4p to 5p on funding completion and good updates on the clinical trial but 7p to 10p no I can’t see until the drugs are approved further down the line. I think even the genuine long term holders will agree 7p to 10p with the dilution over the years is too much a ask